Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effect of Low Dose IL-2 Combined With Rapamycin in on sjögren's Syndrome

NCT05605665 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT05605665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05605665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effect of Low Dose IL-2 Combined With Rapamycin in on sjögren's Syndrome
Lead sponsor
Peking University People's Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
December 5, 2022
Completion date
March 31, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sjögren's syndrome